Bank of America
ALXO icon

Bank of America’s ALX Oncology ALXO Stock Holding History

Bank of America’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.16M Buy
577,783
+45,938
+9% +$87.5K ﹤0.01% 4445
2025
Q4 		$601K Buy
531,845
+1,017
+0.2% +$1.54K ﹤0.01% 4816
2025
Q3 		$971K Sell
530,828
-504,299
-49% -$437K ﹤0.01% 5347
2025
Q2 		$430K Sell
1,035,127
-416,651
-29% -$210K ﹤0.01% 5791
2025
Q1 		$904K Buy
1,451,778
+416,452
+40% +$500K ﹤0.01% 5293
2024
Q4 		$1.73M Buy
1,035,326
+860,703
+493% +$1.32M ﹤0.01% 4573
2024
Q3 		$318K Buy
174,623
+133,613
+326% +$497K ﹤0.01% 5767
2024
Q2 		$247K Sell
41,010
-6,145
-13% -$75.6K ﹤0.01% 5774
2024
Q1 		$526K Sell
47,155
-17,601
-27% -$247K ﹤0.01% 5323
2023
Q4 		$964K Buy
64,756
+13,008
+25% +$123K ﹤0.01% 5011
2023
Q3 		$248K Buy
51,748
+24,447
+90% +$133K ﹤0.01% 5767
2023
Q2 		$205K Buy
27,301
+1,896
+7% +$12.4K ﹤0.01% 5808
2023
Q1 		$115K Sell
25,405
-177,669
-87% -$1.35M ﹤0.01% 6200
2022
Q4 		$2.29M Buy
203,074
+180,868
+815% +$2.03M ﹤0.01% 4124
2022
Q3 		$213K Buy
22,206
+5,332
+32% +$62.1K ﹤0.01% 5934
2022
Q2 		$136K Sell
16,874
-41,807
-71% -$455K ﹤0.01% 6320
2022
Q1 		$992K Sell
58,681
-10,644
-15% -$182K ﹤0.01% 5269
2021
Q4 		$1.49M Buy
69,325
+62,419
+904% +$2.69M ﹤0.01% 4846
2021
Q3 		$509K Buy
6,906
+999
+17% +$66.6K ﹤0.01% 5625
2021
Q2 		$323K Buy
5,907
+2,732
+86% +$163K ﹤0.01% 5751
2021
Q1 		$233K Sell
3,175
-3,935
-55% -$310K ﹤0.01% 5921
2020
Q4 		$613K Sell
7,110
-1,400
-16% -$84.2K ﹤0.01% 4862
2020
Q3 		$321K Buy
+8,510
New +$334K ﹤0.01% 5014

Other funds holding ALXO

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

Bank of America's ALXO Position: Q1 2026 in Review

Bank of America increased its ALX Oncology (ALXO) stake by 8.6% in Q1 2026, buying an estimated $87.5K and bringing the position to 577,783 shares worth $1.16M. The position accounts for ﹤0.01% of the portfolio, ranked #4445.

Bank of America first reported a position in ALXO in Q3 2020 and has held it in 23 quarters since. The position peaked at $2.29M in Q4 2022. 69 funds tracked by Wall St. Rank hold ALXO as of Q1 2026.

  • Bank of America held 577,783 shares of ALX Oncology worth $1.16M as of Q1 2026.
  • Bank of America bought 45,938 ALX Oncology shares in Q1 2026, an estimated $87.5K.
  • ALX Oncology made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4445 holding.
  • Bank of America first reported a position in ALX Oncology in Q3 2020 and has held it in 23 quarters since.
  • Bank of America's ALX Oncology position peaked at $2.29M in Q4 2022.
  • 69 funds tracked by Wall St. Rank held ALX Oncology as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.